Contributions of Interleukin-1 Receptor Signaling in Traumatic Brain Injury

Volume: 13
Published: Jan 21, 2020
Abstract
Traumatic Brain Injury (TBI) in various forms affects millions in the United States annually. There are currently no FDA approved therapies for acute injury or the chronic comorbidities associated with TBI. Acute phases of TBI are characterized by profound neuroinflammation, a process that stimulates the generation and release of proinflammatory cytokines including interleukin-1α (IL-1α) and interleukin-1β (IL-1β). Both forms of IL-1 initiate...
Paper Details
Title
Contributions of Interleukin-1 Receptor Signaling in Traumatic Brain Injury
Published Date
Jan 21, 2020
Volume
13
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.